SCHEMBL23162012

SCHEMBL23162012

N#Cc1nn(Cc2cccnc2)c2c(F)cccc12

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 4/20 0.42
ALDH1A1 P00352 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
KDM4E B2RXH2 2/20 0.40
PKM P14618 1/20 0.40
ABL1 P00519 1/20 0.38
RIN1 Q13671 1/20 0.38
APP P05067 2/20 0.38
SNCA P37840 2/20 0.38
CYP1B1 Q16678 1/20 0.37
GRIN1 Q05586 2/20 0.37
GRIN2B Q13224 2/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNA4 P43681 1/20 0.37
AR P10275 1/20 0.37
CHRM1 P11229 1/20 0.36
UBE2N P61088 1/20 0.36
ATM Q13315 1/20 0.36
CYP11B1 P15538 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23161955 0.88 KCNK13 (0.37) CYP1B1GRIN1GRIN2BCYP11B1
SCHEMBL20534564 0.86 KCNK13 (0.36) P2RX7ALDH1A1KDM4ECYP1B1CYP11B1
SCHEMBL23161999 0.86 ALDH1A1 (0.39) P2RX7ALDH1A1TDP1KDM4EPKM
SCHEMBL23161968 0.84 BUB1 (0.39) PKMCHRM1
SCHEMBL20534565 0.81 P2RX7 (0.44) P2RX7ALDH1A1TDP1KDM4EPKM
SCHEMBL28252589 0.81 P2RX7 (0.42) P2RX7ALDH1A1TDP1KDM4EPKM
SCHEMBL20534347 0.80 APP (0.48) P2RX7ALDH1A1PKMAPPSNCA
SCHEMBL23161936 0.78 NR1H2 (0.41) ALDH1A1KDM4EPKMCHRM1
SCHEMBL20534644 0.77 GRIN1 (0.43) P2RX7ALDH1A1PKMGRIN1GRIN2B
SCHEMBL23161987 0.77 ALDH1A1 (0.39) P2RX7ALDH1A1KDM4EPKMCYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609883-B1 FLUORINE-SUBSTITUTED INDAZOLE COMPOUNDS AND USES THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2022-06-29 EP disclosed
US-11242335-B2 Fluorine-substituted indazole compounds and uses thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-02-08 US disclosed
US-20210101882-A1 FLUORINE-SUBSTITUTED INDAZOLE COMPOUNDS AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2021-04-08 US disclosed
CN-108727340-B Fluorine substituted indazoles and use thereof 广东东阳光药业有限公司 2020-12-29 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11242335-B2 Fluorine-substituted indazole compounds and uses thereof GUCY1B2, GUCY1A2, PDE3A P2RX7 558/4885ALDH1A1 1153/4885TDP1 828/4885
US-20210101882-A1 FLUORINE-SUBSTITUTED INDAZOLE COMPOUNDS AND USES THEREOF PDE3A, PDE3B, PDE5A P2RX7 352/4885ALDH1A1 2047/4885TDP1 601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.